89 related articles for article (PubMed ID: 11087679)
1. Purification of GSK-3 by affinity chromatography on immobilized axin.
Primot A; Baratte B; Gompel M; Borgne A; Liabeuf S; Romette JL; Jho EH; Costantini F; Meijer L
Protein Expr Purif; 2000 Dec; 20(3):394-404. PubMed ID: 11087679
[TBL] [Abstract][Full Text] [Related]
2. Purification of CK1 by affinity chromatography on immobilised axin.
Reinhardt J; Ferandin Y; Meijer L
Protein Expr Purif; 2007 Jul; 54(1):101-9. PubMed ID: 17434749
[TBL] [Abstract][Full Text] [Related]
3. GSK-3beta-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by beta-catenin and protein phosphatase 2A complexed with Axin.
Ikeda S; Kishida M; Matsuura Y; Usui H; Kikuchi A
Oncogene; 2000 Jan; 19(4):537-45. PubMed ID: 10698523
[TBL] [Abstract][Full Text] [Related]
4. Use of a synthetic peptide as a selective substrate for glycogen synthase kinase 3.
Wang QM; Roach PJ; Fiol CJ
Anal Biochem; 1994 Aug; 220(2):397-402. PubMed ID: 7978284
[TBL] [Abstract][Full Text] [Related]
5. Sequence variants of the axin gene in breast, colon, and other cancers: an analysis of mutations that interfere with GSK3 binding.
Webster MT; Rozycka M; Sara E; Davis E; Smalley M; Young N; Dale TC; Wooster R
Genes Chromosomes Cancer; 2000 Aug; 28(4):443-53. PubMed ID: 10862053
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of the phosphorylation of beta-catenin at the GSK-3 priming site Ser45.
Hagen T; Vidal-Puig A
Biochem Biophys Res Commun; 2002 Jun; 294(2):324-8. PubMed ID: 12051714
[TBL] [Abstract][Full Text] [Related]
7. Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice.
Lucas JJ; Hernández F; Gómez-Ramos P; Morán MA; Hen R; Avila J
EMBO J; 2001 Jan; 20(1-2):27-39. PubMed ID: 11226152
[TBL] [Abstract][Full Text] [Related]
8. The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease.
Leroy K; Boutajangout A; Authelet M; Woodgett JR; Anderton BH; Brion JP
Acta Neuropathol; 2002 Feb; 103(2):91-9. PubMed ID: 11810173
[TBL] [Abstract][Full Text] [Related]
9. Nuclear glycogen and glycogen synthase kinase 3.
Ragano-Caracciolo M; Berlin WK; Miller MW; Hanover JA
Biochem Biophys Res Commun; 1998 Aug; 249(2):422-7. PubMed ID: 9712712
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine dephosphorylation and concurrent inactivation of protein kinase FA/GSK-3 alpha by genistein in A431 cells.
Yu JS; Yang SD
J Cell Biochem; 1994 Sep; 56(1):131-41. PubMed ID: 7806586
[TBL] [Abstract][Full Text] [Related]
11. Glycogen synthase kinase-3 and dorsoventral patterning in Xenopus embryos.
He X; Saint-Jeannet JP; Woodgett JR; Varmus HE; Dawid IB
Nature; 1995 Apr; 374(6523):617-22. PubMed ID: 7715701
[TBL] [Abstract][Full Text] [Related]
12. Peptide substrates suitable for assaying glycogen synthase kinase-3 in crude cell extracts.
Welsh GI; Patel JC; Proud CG
Anal Biochem; 1997 Jan; 244(1):16-21. PubMed ID: 9025901
[TBL] [Abstract][Full Text] [Related]
13. Pancreastatin, a chromogranin-A-derived peptide, inhibits insulin-stimulated glycogen synthesis by activating GSK-3 in rat adipocytes.
González-Yanes C; Sánchez-Margalet V
Biochem Biophys Res Commun; 2001 Nov; 289(1):282-7. PubMed ID: 11708813
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of glycogen synthase kinase-3 represses androgen receptor activity and prostate cancer cell growth.
Mazor M; Kawano Y; Zhu H; Waxman J; Kypta RM
Oncogene; 2004 Oct; 23(47):7882-92. PubMed ID: 15361837
[TBL] [Abstract][Full Text] [Related]
15. Identification of the Axin and Frat binding region of glycogen synthase kinase-3.
Fraser E; Young N; Dajani R; Franca-Koh J; Ryves J; Williams RS; Yeo M; Webster MT; Richardson C; Smalley MJ; Pearl LH; Harwood A; Dale TC
J Biol Chem; 2002 Jan; 277(3):2176-85. PubMed ID: 11707456
[TBL] [Abstract][Full Text] [Related]
16. Xenopus axin interacts with glycogen synthase kinase-3 beta and is expressed in the anterior midbrain.
Hedgepeth CM; Deardorff MA; Klein PS
Mech Dev; 1999 Feb; 80(2):147-51. PubMed ID: 10072781
[TBL] [Abstract][Full Text] [Related]
17. Glycogen synthase kinase-3 beta mutagenesis identifies a common binding domain for GBP and Axin.
Ferkey DM; Kimelman D
J Biol Chem; 2002 May; 277(18):16147-52. PubMed ID: 11861647
[TBL] [Abstract][Full Text] [Related]
18. Dysfunction of protein kinase FA/GSK-3 alpha in lymphocytes of patients with schizophrenic disorder.
Yang SD; Yu JS; Lee TT; Yang CC; Ni MH; Yang YY
J Cell Biochem; 1995 Sep; 59(1):108-16. PubMed ID: 8530529
[TBL] [Abstract][Full Text] [Related]
19. Immobilized hirudin and hirudin-based peptides used for the purification of recombinant human thrombin prepared from recombinant human prothrombin.
Fischer BE; Mitterer A; Schlokat U; Grillberger L; Reiter M; Mundt W; Dorner F; Eibl J
Protein Expr Purif; 1996 Sep; 8(2):167-74. PubMed ID: 8812854
[TBL] [Abstract][Full Text] [Related]
20. Plasmodium falciparum glycogen synthase kinase-3: molecular model, expression, intracellular localisation and selective inhibitors.
Droucheau E; Primot A; Thomas V; Mattei D; Knockaert M; Richardson C; Sallicandro P; Alano P; Jafarshad A; Baratte B; Kunick C; Parzy D; Pearl L; Doerig C; Meijer L
Biochim Biophys Acta; 2004 Mar; 1697(1-2):181-96. PubMed ID: 15023360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
